Healthcare Regulation (HIPAA)

Amid a regional healthcare crisis, 475 nurses at BMC South plan to picket, citing unsafe staffing and a 'bullying' contract offer from management.

New data on 20,000+ exams reveals a shocking weakness in first aid for common injuries, prompting a call to reform California's certification standards.

With millions set to lose Medicaid under new federal rules, Azara Healthcare’s acquisition of Advocatia creates a new tech arsenal for at-risk providers.

Eli Lilly's partnership with cash-pay platform Sesame is more than a deal; it's a blueprint for a decentralized, direct-to-consumer healthcare market.

A 2027 CMS mandate and AI pioneers like Humata Health are racing to fix prior authorization. But can technology truly untangle healthcare's notorious red tape?

New data showing a 300% spike in demand for Burmese prescription translations is a stark economic signal of a deeper demographic shift challenging U.S. healthcare.

With record device sales providing a solid financial base, RenovoRx nears a critical milestone in its high-stakes Phase III trial for a new pancreatic cancer therapy.

A key regulatory win in Japan propels a potential first-ever treatment for Netherton Syndrome, but the real story is the high-wire act of global commercialization.

The renewed pact between PENTAX Medical and FUJIFILM promises over a decade of support for their EUS systems, a strategic move in a booming med-tech market.

As AI sweeps through medicine, Gigi Yuen-Reed's recognition highlights a crucial strategy: building systems that empower, not replace, human expertise.

At Money20/20, one firm showed how legal precedent and a patent moat are turning digital trust from a compliance headache into a core business asset.

SciSparc's subsidiary just spent nearly C$10M on a quantum computing firm. This is the operational innovation designed to fix billion-dollar clinical trial failures.

A new diagnostic tool, Delve Detect, is using metagenomic sequencing to unmask elusive pathogens in the brain, offering hope where conventional tests fail.

As security leaders prepare for the Gartner Summit, a new analyst watch list offers a roadmap to the AI-driven vendors and trends shaping the industry's bottom line.

A record verdict in a retaining wall collapse reveals more than a local tragedy; it exposes a systemic breakdown in safety, regulation, and corporate risk.

ADC Therapeutics' lymphoma drug ZYNLONTA shows promise in a Phase 3 trial, but a concerning safety signal in older patients complicates its path to market.

Fairplay's new user verification signals a market-wide shift. As India's stringent new rules take hold, compliance is becoming a key strategic asset.

A new partnership with Scala.AI aims to move beyond simple telehealth, using deep operational intelligence to fix healthcare's costly fragmentation and poor navigation.

Physicians are being warned about indemnification clauses in contracts that can shift immense liability. Here's what doctors need to know to avoid financial ruin.

Eyebot and The Framery's new partnership offers 15-minute prescriptions via mall kiosks, blending tech and retail. But can this model truly disrupt the optical industry?